Teens Age 12-17 with Asthma

Trial Objective

Teen Asthma Investigational MedicationThe purpose of this study is to determine if an investigational medication, Fevipiprant, improves breathing in teens with uncontrolled asthma.

Study details:

  • 9 visits to National Jewish Health over a 5 month period
  • Investigational medicine is taken in addition to standard-of-care therapy and is in the form of a pill
  • Medical evaluations (including breathing tests and physical examinations) at no cose
  • Asthma education
  • Financial compensation for time and travel for qualified participants

Enrollment

New enrollment for this trial is temporarily paused

Who Can Participate

Teens age 12-17 with a diagnosis of asthma for at least six months who are being treated with daily asthma medications may be eligible to participate.

Age: 12-17    Gender: Any Gender


Estimated Time Commitment

About 9 visits over approximately 19 weeks



Payment & Reimbursement  

Payment: Provided

Travel Reimbursement: Not Available

Trial Contact

For more information, contact:

Michael White

Michael White
303.398.1470

D Sundstrom

Dee Sundstrom
303.398.1470

Request More Information

Trial Location

National Jewish Main Campus, Denver, CO

Trial Sponsors

Novartis Pharmaceuticals Corporation


Request More Information

Due to concerns around COVID-19 and our focus on helping to meet this momentous challenge, we have temporarily paused enrollment for all trials requiring an in-person visit. Please feel free to request additional information about any of the trials we have posted and we will get back to you when enrollment resumes. For more resources and information on COVID-19 please visit our special coronavirus website at www.njhealth.org/coronavirus.


*
*
*
*